1,043
Participants
Start Date
February 11, 2014
Primary Completion Date
September 21, 2018
Study Completion Date
September 21, 2018
Roxadustat
Roxadustat will be administered per dose and schedule specified in the arm.
Epoetin Alfa
Epoetin alfa will be administered TIW according to the epoetin alfa USPI or SmPC, or local SOC.
Investigational Site,, New Taipei City
Investigational Site, Taichung
Investigational Site, Sofia
Investigational Site, Sofia
Investigational site, Sofia
Investigational Site, Sofia
Investigational Site, Serandi
Investigational site, Pernik
Investigational Site, Plovdiv
Investigational site, Pazardzhik
Investigational Site, Pleven
Invesigational Site, Stara Zagora
Investigational site, Rousse
Investigational Site, Burgas
Investigational Site, Varna
Investigational site, Dobrich
Investigational Site, Bangkok
Investigational Site, George Town
Investigational Site, Aguascalientes
Investigational Site, Durham
Investigational Site, New Bern
Investigational Site, Orangeburg
Investigational Site, Sumter
Investigational Site, Columbia
Investigational Site, Coral Springs
Investigational Site, Miami
Investigational Site, Miami
Investigational Site, Tampa
Investigational Site, Taiping
Investigational Site, Knoxville
Investigational Site, Tupelo
Investigational Site, Portsmouth
Investigational Site, Gulfport
Investigational Site, Brookhaven
Investigational Site, Columbus
Investigational Site, Taichung
Investigational Site, Kuala Lumpur
Investigational Site, Columbus
Investigational Site, Ternopil
Investigational Site, Detroit
Investigational Site, Pontiac
Investigational Site, Chiang Mai
Investigational Site, Kuala Lumpur
Investigational Site, Mykolayiv
Investigational Site, Karkiev
Investigational Site, Saint Ann
Investigational Site, St Louis
Investigational Site, Zaporizhzhya
Investigational Site, Zaporizhzhya
Investigational Site, Shreveport
Investigational Site, Ivano
Investigational Site, Houston
Investigational Site, Houston
Investigational Site, San Luis Potosí City
Investigational Site, Edinburg
Investigational Site, Kaohsiung City
Meridian, Meridian
Investigational Site, Albuquerque
Investigational Site, Chula Vista
Investigational Site, La Mesa
Investigational Site, San Diego
Investigational Site, Miri
Investigational Site, Moscow
Investigational Site, Moscow
investigational Site, Moscow
Investigational Site, Kolomna
Investigational Site, Rostov-on-Don
Investigational Site, Petrozavodsk
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational site, Saint Petersburg
Investigational Site, Saint Petersburg
Investigational Site, Craiova
Investigational Site, Smolensk
Investigational Site, Slatina
Investigational Site, Kaluga
Investigational Site, Krasnodar
Investigational Site, Krasnodar
Investigational Site, Novorossiysk
Investigational Site, Orenburg
Investigational Site, Târgu Mureş
Investigational Site, Nizhny Novgorod
Investigational site, Omsk
Investigational Site, La Serena
Investigational Site, Temuco
Investigational Site, Lauderdale Lakes
Investigational Site, Santa Fe
Investigational Site, Barranquilla
Investigational Site, Barranquilla
Investigational Site, Riga
Invetigational Site, Riga
Investigational Site, Ventspils
Investigational Site, Alor Star
Investigational Site, Chorzów
Investigational Site, Golub-Dobrzyń
Investigational Site, Inowrocław
Investigational Site, Katowice
Investigational Drug, Pruszków
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational Site, Bucharest
Investigational site, Goyang-si
Investigational Site, Guri-si
Investigational Site, Seongnam-si
Investigational Site, Anyang-si
Investigational Site, Seoul
Investigational Site, Seoul
Investigational Site, Kiev
Lead Sponsor
Collaborators (1)
Astellas Pharma Europe B.V.
INDUSTRY
AstraZeneca
INDUSTRY
FibroGen
INDUSTRY